What's New on the FDA Drugs Site
July 2, 2015
- Drug Firm Annual Registration Status Download File (updated)
- Drug Supply Chain Security Act (DSCSA) (updated)
- FDA approves Orkambi (lumacaftor 200 mg/ivacaftor 125 mg), a new treatment for cystic fibrosis
- FDA warns consumers who purchase Diazepam online of potentially serious counterfeiting issue
- National Drug Code Directory
- Pediatric Medical, Statistical, and Clinical Pharmacology BPCA Reviews (updated)
- Public Notification: Akttive Capsules contain hidden drug ingredients
- Public Notification: Zero Xtreme Capsules contain hidden drug ingredients
- Warning Letters 2015 (updated)
No hay comentarios:
Publicar un comentario